Cholangiocarcinoma of the Gallbladder Completed Phase 1 Trials for ADH-1 (DB05485)

IndicationStatusPhase
DBCOND0029558 (Cholangiocarcinoma of the Gallbladder)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01825603ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed by SurgeryTreatment